LOS ANGELES CAPITAL MANAGEMENT LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$357,000
-0.3%
123,970
+5.3%
0.00%0.0%
Q4 2021$358,000
-64.3%
117,681
-17.7%
0.00%
-80.0%
Q3 2021$1,002,000
+312.3%
142,941
+439.6%
0.01%
+400.0%
Q2 2021$243,000
+64.2%
26,489
+73.6%
0.00%0.0%
Q1 2021$148,000
-81.8%
15,259
-80.4%
0.00%
-75.0%
Q2 2020$812,000
+46.0%
77,816
+18.2%
0.00%0.0%
Q1 2020$556,000
+23.3%
65,861
+27.7%
0.00%
+100.0%
Q4 2019$451,000
+62.2%
51,591
+99.9%
0.00%0.0%
Q3 2019$278,000
-17.8%
25,806
+196.1%
0.00%0.0%
Q1 2019$338,000
-44.8%
8,714
-34.7%
0.00%
-33.3%
Q3 2018$612,000
-79.5%
13,339
-73.5%
0.00%
-81.2%
Q2 2018$2,981,000
+80.4%
50,399
+107.6%
0.02%
+77.8%
Q1 2018$1,652,000
+439.9%
24,279
+850.6%
0.01%
+350.0%
Q3 2017$306,000
-61.7%
2,554
-90.5%
0.00%
-71.4%
Q2 2016$798,000
+179.0%
26,794
+994.1%
0.01%
+133.3%
Q2 2015$286,000
-67.7%
2,449
-34.8%
0.00%
-62.5%
Q1 2015$886,0003,7540.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$13,338,0002.17%
Camber Capital Management LP 2,555,000$26,214,0000.92%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,959,741$40,627,0000.80%
Palo Alto Investors LP 1,373,897$14,096,0000.74%
Sofinnova Investments, Inc. 629,650$6,460,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 604,937$6,207,0000.22%
J. Goldman & Co LP 238,617$2,448,0000.12%
GLOBEFLEX CAPITAL L P 55,027$565,0000.12%
FRED ALGER MANAGEMENT, LLC 3,416,003$35,048,0000.09%
JUPITER ASSET MANAGEMENT LTD 728,440$7,474,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders